Sandia Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-7,500	Closed	-$308K	–	111
2024 Q2	$308K	Buy	+7,500	New	+$308K	0.38%	52